- Home
- UBFO vs TIL Comparison
UBFO vs TIL Comparison
Compare UBFO & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBFO
- TIL
- Stock Information
- Founded
- UBFO 1987
- TIL 2018
- Country
- UBFO United States
- TIL United States
- Employees
- UBFO N/A
- TIL N/A
- Industry
- UBFO Major Banks
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- UBFO Finance
- TIL Health Care
- Exchange
- UBFO Nasdaq
- TIL Nasdaq
- Market Cap
- UBFO 154.8M
- TIL 177.1M
- IPO Year
- UBFO N/A
- TIL 2021
- Fundamental
- Price
- UBFO $9.27
- TIL $18.16
- Analyst Decision
- UBFO
- TIL Strong Buy
- Analyst Count
- UBFO 0
- TIL 5
- Target Price
- UBFO N/A
- TIL $100.67
- AVG Volume (30 Days)
- UBFO 24.1K
- TIL 184.6K
- Earning Date
- UBFO 10-17-2025
- TIL 11-12-2025
- Dividend Yield
- UBFO 5.19%
- TIL N/A
- EPS Growth
- UBFO N/A
- TIL N/A
- EPS
- UBFO 0.65
- TIL N/A
- Revenue
- UBFO $44,636,000.00
- TIL N/A
- Revenue This Year
- UBFO N/A
- TIL N/A
- Revenue Next Year
- UBFO N/A
- TIL N/A
- P/E Ratio
- UBFO $14.13
- TIL N/A
- Revenue Growth
- UBFO N/A
- TIL N/A
- 52 Week Low
- UBFO $7.32
- TIL $10.80
- 52 Week High
- UBFO $10.49
- TIL $48.60
- Technical
- Relative Strength Index (RSI)
- UBFO 45.71
- TIL 40.22
- Support Level
- UBFO $9.05
- TIL $17.38
- Resistance Level
- UBFO $9.53
- TIL $19.50
- Average True Range (ATR)
- UBFO 0.25
- TIL 1.60
- MACD
- UBFO -0.07
- TIL 0.04
- Stochastic Oscillator
- UBFO 25.58
- TIL 34.90
About UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.